Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report)’s share price traded down 5.7% during trading on Wednesday . The stock traded as low as $27.72 and last traded at $27.72. 420 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 36,775 shares. The stock had previously closed at $29.39.
Wall Street Analyst Weigh In
Separately, Zacks Research upgraded shares of Otsuka from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 9th. One equities research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Strong Buy”.
View Our Latest Stock Analysis on OTSKY
Otsuka Trading Down 1.6%
Otsuka Company Profile
Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.
Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.
Featured Stories
- Five stocks we like better than Otsuka
- NEW LAW: Congress Approves Setup For Digital Dollar?
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
